nodes	percent_of_prediction	percent_of_DWPC	metapath
Cocaine—SCN5A—Riluzole—amyotrophic lateral sclerosis	0.887	1	CbGbCtD
Cocaine—SCN11A—peripheral nervous system—amyotrophic lateral sclerosis	0.0117	0.147	CbGeAlD
Cocaine—SCN11A—nerve—amyotrophic lateral sclerosis	0.00912	0.114	CbGeAlD
Cocaine—SCN10A—peripheral nervous system—amyotrophic lateral sclerosis	0.00593	0.0745	CbGeAlD
Cocaine—SCN10A—nerve—amyotrophic lateral sclerosis	0.00463	0.0581	CbGeAlD
Cocaine—SLC6A3—nerve—amyotrophic lateral sclerosis	0.00357	0.0448	CbGeAlD
Cocaine—SLC6A2—nerve—amyotrophic lateral sclerosis	0.00288	0.0361	CbGeAlD
Cocaine—SLC6A3—hindbrain—amyotrophic lateral sclerosis	0.00267	0.0335	CbGeAlD
Cocaine—SLC6A4—hindbrain—amyotrophic lateral sclerosis	0.00245	0.0307	CbGeAlD
Cocaine—SCN11A—spinal cord—amyotrophic lateral sclerosis	0.00244	0.0306	CbGeAlD
Cocaine—SCN11A—nervous system—amyotrophic lateral sclerosis	0.00205	0.0257	CbGeAlD
Cocaine—SCN11A—central nervous system—amyotrophic lateral sclerosis	0.00198	0.0248	CbGeAlD
Cocaine—SCN11A—brain—amyotrophic lateral sclerosis	0.00157	0.0197	CbGeAlD
Cocaine—SLC6A3—brainstem—amyotrophic lateral sclerosis	0.00153	0.0192	CbGeAlD
Cocaine—SLC6A4—brainstem—amyotrophic lateral sclerosis	0.0014	0.0176	CbGeAlD
Cocaine—SLC6A2—brainstem—amyotrophic lateral sclerosis	0.00124	0.0155	CbGeAlD
Cocaine—SCN10A—spinal cord—amyotrophic lateral sclerosis	0.00123	0.0155	CbGeAlD
Cocaine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00118	0.0148	CbGeAlD
Cocaine—SCN10A—nervous system—amyotrophic lateral sclerosis	0.00104	0.0131	CbGeAlD
Cocaine—SCN10A—central nervous system—amyotrophic lateral sclerosis	0.001	0.0126	CbGeAlD
Cocaine—SLC6A3—spinal cord—amyotrophic lateral sclerosis	0.000953	0.012	CbGeAlD
Cocaine—SCN5A—nervous system—amyotrophic lateral sclerosis	0.000946	0.0119	CbGeAlD
Cocaine—SCN5A—central nervous system—amyotrophic lateral sclerosis	0.00091	0.0114	CbGeAlD
Cocaine—SLC6A4—spinal cord—amyotrophic lateral sclerosis	0.000873	0.011	CbGeAlD
Cocaine—SLC6A2—medulla oblongata—amyotrophic lateral sclerosis	0.000862	0.0108	CbGeAlD
Cocaine—CHRM2—nervous system—amyotrophic lateral sclerosis	0.000805	0.0101	CbGeAlD
Cocaine—SLC6A3—nervous system—amyotrophic lateral sclerosis	0.000803	0.0101	CbGeAlD
Cocaine—SCN10A—brain—amyotrophic lateral sclerosis	0.000795	0.00998	CbGeAlD
Cocaine—CHRM2—central nervous system—amyotrophic lateral sclerosis	0.000775	0.00973	CbGeAlD
Cocaine—SLC6A3—central nervous system—amyotrophic lateral sclerosis	0.000773	0.0097	CbGeAlD
Cocaine—SLC6A3—cerebellum—amyotrophic lateral sclerosis	0.000755	0.00948	CbGeAlD
Cocaine—SLC6A4—nervous system—amyotrophic lateral sclerosis	0.000736	0.00923	CbGeAlD
Cocaine—CHRM1—nervous system—amyotrophic lateral sclerosis	0.000733	0.00919	CbGeAlD
Cocaine—SCN5A—brain—amyotrophic lateral sclerosis	0.000723	0.00907	CbGeAlD
Cocaine—SLC6A4—central nervous system—amyotrophic lateral sclerosis	0.000708	0.00889	CbGeAlD
Cocaine—CHRM1—central nervous system—amyotrophic lateral sclerosis	0.000706	0.00885	CbGeAlD
Cocaine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.000677	0.00849	CbGeAlD
Cocaine—SLC6A2—nervous system—amyotrophic lateral sclerosis	0.000648	0.00813	CbGeAlD
Cocaine—SLC6A2—central nervous system—amyotrophic lateral sclerosis	0.000624	0.00782	CbGeAlD
Cocaine—CHRM2—brain—amyotrophic lateral sclerosis	0.000615	0.00772	CbGeAlD
Cocaine—SLC6A3—brain—amyotrophic lateral sclerosis	0.000614	0.0077	CbGeAlD
Cocaine—SLC6A4—brain—amyotrophic lateral sclerosis	0.000562	0.00705	CbGeAlD
Cocaine—CHRM1—brain—amyotrophic lateral sclerosis	0.00056	0.00703	CbGeAlD
Cocaine—SLC6A2—brain—amyotrophic lateral sclerosis	0.000495	0.00621	CbGeAlD
Cocaine—CYP2C8—brain—amyotrophic lateral sclerosis	0.000407	0.0051	CbGeAlD
Cocaine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00036	0.00452	CbGeAlD
Cocaine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000355	0.00445	CbGeAlD
Cocaine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000347	0.00435	CbGeAlD
Cocaine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000341	0.00428	CbGeAlD
Cocaine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000334	0.00419	CbGeAlD
Cocaine—CYP2D6—brain—amyotrophic lateral sclerosis	0.000271	0.0034	CbGeAlD
Cocaine—SLC22A2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000121	0.00368	CbGpPWpGaD
Cocaine—SLC6A4—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000121	0.00367	CbGpPWpGaD
Cocaine—SLC6A3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00012	0.00365	CbGpPWpGaD
Cocaine—CYP3A5—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000119	0.00361	CbGpPWpGaD
Cocaine—CYP2D6—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000119	0.00361	CbGpPWpGaD
Cocaine—SLC6A3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000118	0.00361	CbGpPWpGaD
Cocaine—SLC6A3—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000117	0.00358	CbGpPWpGaD
Cocaine—SLC22A2—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000115	0.00351	CbGpPWpGaD
Cocaine—CYP2C8—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000114	0.00346	CbGpPWpGaD
Cocaine—SLC22A2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000113	0.00344	CbGpPWpGaD
Cocaine—SLC6A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000113	0.00344	CbGpPWpGaD
Cocaine—SCN5A—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.00011	0.00337	CbGpPWpGaD
Cocaine—SLC6A4—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.00011	0.00335	CbGpPWpGaD
Cocaine—SLC6A3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00011	0.00334	CbGpPWpGaD
Cocaine—SLC22A2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000109	0.00332	CbGpPWpGaD
Cocaine—SLC6A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000108	0.0033	CbGpPWpGaD
Cocaine—SLC22A2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000108	0.00328	CbGpPWpGaD
Cocaine—SLC6A3—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000108	0.00328	CbGpPWpGaD
Cocaine—SLC6A2—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000104	0.00316	CbGpPWpGaD
Cocaine—CYP2C8—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000103	0.00313	CbGpPWpGaD
Cocaine—SLC6A3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000102	0.0031	CbGpPWpGaD
Cocaine—SLC6A3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000102	0.0031	CbGpPWpGaD
Cocaine—SLC6A3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	9.99e-05	0.00304	CbGpPWpGaD
Cocaine—SLC22A2—Neuronal System—NEFL—amyotrophic lateral sclerosis	9.97e-05	0.00304	CbGpPWpGaD
Cocaine—SLC22A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	9.8e-05	0.00299	CbGpPWpGaD
Cocaine—SLC6A3—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	9.6e-05	0.00293	CbGpPWpGaD
Cocaine—SLC22A2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	9.27e-05	0.00282	CbGpPWpGaD
Cocaine—SLC22A2—Neuronal System—CHAT—amyotrophic lateral sclerosis	9.27e-05	0.00282	CbGpPWpGaD
Cocaine—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.24e-05	0.00282	CbGpPWpGaD
Cocaine—SLC6A3—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	9.19e-05	0.0028	CbGpPWpGaD
Cocaine—SLC22A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	9.09e-05	0.00277	CbGpPWpGaD
Cocaine—SLC6A3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	9.08e-05	0.00277	CbGpPWpGaD
Cocaine—CHRM2—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	9.06e-05	0.00276	CbGpPWpGaD
Cocaine—CHRM1—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	8.78e-05	0.00268	CbGpPWpGaD
Cocaine—SLC22A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	8.74e-05	0.00266	CbGpPWpGaD
Cocaine—CYP2D6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	8.44e-05	0.00257	CbGpPWpGaD
Cocaine—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	8.36e-05	0.00255	CbGpPWpGaD
Cocaine—SLC22A2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	8.26e-05	0.00252	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	7.91e-05	0.00241	CbGpPWpGaD
Cocaine—CYP3A7—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	7.34e-05	0.00224	CbGpPWpGaD
Cocaine—CHRM1—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	7.3e-05	0.00222	CbGpPWpGaD
Cocaine—SLC6A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	7.27e-05	0.00221	CbGpPWpGaD
Cocaine—CYP3A7—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	7.24e-05	0.00221	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	7.24e-05	0.0022	CbGpPWpGaD
Cocaine—CHRM2—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	7.21e-05	0.0022	CbGpPWpGaD
Cocaine—SCN11A—Axon guidance—MMP9—amyotrophic lateral sclerosis	7.2e-05	0.00219	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	6.73e-05	0.00205	CbGpPWpGaD
Cocaine—CHRM2—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	6.51e-05	0.00198	CbGpPWpGaD
Cocaine—SCN11A—Axon guidance—VEGFA—amyotrophic lateral sclerosis	6.47e-05	0.00197	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	6.44e-05	0.00196	CbGpPWpGaD
Cocaine—SLC6A3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	6.44e-05	0.00196	CbGpPWpGaD
Cocaine—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	6.4e-05	0.00195	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	6.32e-05	0.00193	CbGpPWpGaD
Cocaine—SCN5A—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	6.3e-05	0.00192	CbGpPWpGaD
Cocaine—SLC6A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	6.18e-05	0.00188	CbGpPWpGaD
Cocaine—SLC6A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	6.18e-05	0.00188	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	5.89e-05	0.00179	CbGpPWpGaD
Cocaine—SLC22A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	5.86e-05	0.00178	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—TPK1—amyotrophic lateral sclerosis	5.63e-05	0.00171	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—VAPB—amyotrophic lateral sclerosis	5.63e-05	0.00171	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—VAPB—amyotrophic lateral sclerosis	5.62e-05	0.00171	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—TPK1—amyotrophic lateral sclerosis	5.62e-05	0.00171	CbGpPWpGaD
Cocaine—CHRM1—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	5.56e-05	0.00169	CbGpPWpGaD
Cocaine—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	5.52e-05	0.00168	CbGpPWpGaD
Cocaine—SLC6A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	5.51e-05	0.00168	CbGpPWpGaD
Cocaine—SLC6A4—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	5.5e-05	0.00168	CbGpPWpGaD
Cocaine—CHRM2—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	5.49e-05	0.00167	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	5.48e-05	0.00167	CbGpPWpGaD
Cocaine—SLC6A3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	5.47e-05	0.00167	CbGpPWpGaD
Cocaine—SLC6A3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	5.47e-05	0.00167	CbGpPWpGaD
Cocaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	5.35e-05	0.00163	CbGpPWpGaD
Cocaine—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.31e-05	0.00162	CbGpPWpGaD
Cocaine—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	5.24e-05	0.0016	CbGpPWpGaD
Cocaine—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	5.21e-05	0.00159	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	5.15e-05	0.00157	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—VAPA—amyotrophic lateral sclerosis	5.15e-05	0.00157	CbGpPWpGaD
Cocaine—SCN11A—Developmental Biology—MMP9—amyotrophic lateral sclerosis	5.14e-05	0.00157	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—VAPA—amyotrophic lateral sclerosis	5.14e-05	0.00157	CbGpPWpGaD
Cocaine—SLC22A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	4.98e-05	0.00152	CbGpPWpGaD
Cocaine—SLC22A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	4.98e-05	0.00152	CbGpPWpGaD
Cocaine—SLC6A3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	4.88e-05	0.00149	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.79e-05	0.00146	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.78e-05	0.00146	CbGpPWpGaD
Cocaine—SCN10A—Axon guidance—MMP9—amyotrophic lateral sclerosis	4.72e-05	0.00144	CbGpPWpGaD
Cocaine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	4.67e-05	0.00142	CbGpPWpGaD
Cocaine—SCN11A—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	4.62e-05	0.00141	CbGpPWpGaD
Cocaine—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.6e-05	0.0014	CbGpPWpGaD
Cocaine—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.53e-05	0.00138	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—FIG4—amyotrophic lateral sclerosis	4.5e-05	0.00137	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—FIG4—amyotrophic lateral sclerosis	4.49e-05	0.00137	CbGpPWpGaD
Cocaine—SLC22A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	4.44e-05	0.00135	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	4.33e-05	0.00132	CbGpPWpGaD
Cocaine—SCN10A—Axon guidance—VEGFA—amyotrophic lateral sclerosis	4.24e-05	0.00129	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—DAO—amyotrophic lateral sclerosis	4.07e-05	0.00124	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	4.07e-05	0.00124	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	4.07e-05	0.00124	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—DAO—amyotrophic lateral sclerosis	4.06e-05	0.00124	CbGpPWpGaD
Cocaine—CHRM2—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	3.96e-05	0.00121	CbGpPWpGaD
Cocaine—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.77e-05	0.00115	CbGpPWpGaD
Cocaine—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.74e-05	0.00114	CbGpPWpGaD
Cocaine—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.72e-05	0.00113	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	3.72e-05	0.00113	CbGpPWpGaD
Cocaine—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.69e-05	0.00112	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.53e-05	0.00107	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	3.52e-05	0.00107	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	3.52e-05	0.00107	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.46e-05	0.00105	CbGpPWpGaD
Cocaine—SCN10A—Developmental Biology—MMP9—amyotrophic lateral sclerosis	3.37e-05	0.00103	CbGpPWpGaD
Cocaine—SCN5A—Axon guidance—MMP9—amyotrophic lateral sclerosis	3.32e-05	0.00101	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.29e-05	0.001	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	3.25e-05	0.000991	CbGpPWpGaD
Cocaine—CHRM2—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	3.25e-05	0.00099	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	3.22e-05	0.000982	CbGpPWpGaD
Cocaine—CHRM1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	3.19e-05	0.000971	CbGpPWpGaD
Cocaine—CHRM2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	3.15e-05	0.000958	CbGpPWpGaD
Cocaine—CHRM1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	3.14e-05	0.000957	CbGpPWpGaD
Cocaine—CHRM2—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	3.1e-05	0.000945	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—PLB1—amyotrophic lateral sclerosis	3.08e-05	0.000939	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—PLB1—amyotrophic lateral sclerosis	3.08e-05	0.000938	CbGpPWpGaD
Cocaine—SCN10A—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	3.03e-05	0.000922	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	3e-05	0.000913	CbGpPWpGaD
Cocaine—SCN5A—Axon guidance—VEGFA—amyotrophic lateral sclerosis	2.98e-05	0.000908	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	2.94e-05	0.000896	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	2.89e-05	0.000881	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	2.89e-05	0.000881	CbGpPWpGaD
Cocaine—SLC6A4—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	2.88e-05	0.000877	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	2.87e-05	0.000874	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	2.87e-05	0.000874	CbGpPWpGaD
Cocaine—CHRM1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	2.85e-05	0.000869	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—GSR—amyotrophic lateral sclerosis	2.85e-05	0.000867	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—GSR—amyotrophic lateral sclerosis	2.84e-05	0.000866	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	2.82e-05	0.000858	CbGpPWpGaD
Cocaine—CHRM2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	2.82e-05	0.000858	CbGpPWpGaD
Cocaine—CHRM2—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	2.76e-05	0.00084	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.67e-05	0.000815	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	2.65e-05	0.000806	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	2.62e-05	0.000799	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	2.55e-05	0.000776	CbGpPWpGaD
Cocaine—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.47e-05	0.000752	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.46e-05	0.000749	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.44e-05	0.000743	CbGpPWpGaD
Cocaine—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.43e-05	0.000742	CbGpPWpGaD
Cocaine—CHRM1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	2.43e-05	0.000739	CbGpPWpGaD
Cocaine—CHRM2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	2.4e-05	0.00073	CbGpPWpGaD
Cocaine—SCN5A—Developmental Biology—MMP9—amyotrophic lateral sclerosis	2.37e-05	0.000722	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—CHAT—amyotrophic lateral sclerosis	2.34e-05	0.000712	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—CHAT—amyotrophic lateral sclerosis	2.33e-05	0.000711	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	2.31e-05	0.000705	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	2.29e-05	0.000698	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	2.23e-05	0.000679	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	2.22e-05	0.000677	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	2.19e-05	0.000669	CbGpPWpGaD
Cocaine—SCN5A—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	2.13e-05	0.000648	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	2.09e-05	0.000637	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	2.09e-05	0.000637	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	2.07e-05	0.000632	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	2.06e-05	0.000629	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	2.06e-05	0.000627	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.98e-05	0.000604	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.96e-05	0.000596	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	1.93e-05	0.000588	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.92e-05	0.000585	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.89e-05	0.000577	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1.89e-05	0.000576	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1.89e-05	0.000576	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	1.78e-05	0.000543	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	1.73e-05	0.000527	CbGpPWpGaD
Cocaine—CHRM1—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	1.72e-05	0.000525	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.7e-05	0.000519	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	1.69e-05	0.000515	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.69e-05	0.000513	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.68e-05	0.000513	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.66e-05	0.000507	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.62e-05	0.000494	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.61e-05	0.00049	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.58e-05	0.000483	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	1.57e-05	0.000479	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.51e-05	0.000461	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	1.46e-05	0.000446	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	1.46e-05	0.000446	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	1.45e-05	0.000442	CbGpPWpGaD
Cocaine—CHRM1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.41e-05	0.000429	CbGpPWpGaD
Cocaine—CHRM2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.39e-05	0.000424	CbGpPWpGaD
Cocaine—CHRM1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.37e-05	0.000418	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	1.37e-05	0.000417	CbGpPWpGaD
Cocaine—CHRM2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.35e-05	0.000412	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.34e-05	0.000407	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.32e-05	0.000402	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.26e-05	0.000383	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.25e-05	0.000382	CbGpPWpGaD
Cocaine—CHRM1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.25e-05	0.000379	CbGpPWpGaD
Cocaine—CHRM2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.23e-05	0.000374	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.2e-05	0.000366	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	1.19e-05	0.000363	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.16e-05	0.000353	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.15e-05	0.000352	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.15e-05	0.000351	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.14e-05	0.000348	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.09e-05	0.000331	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.09e-05	0.000331	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.07e-05	0.000327	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	1.04e-05	0.000316	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.03e-05	0.000315	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.02e-05	0.000311	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	9.56e-06	0.000291	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	9.5e-06	0.000289	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—APOE—amyotrophic lateral sclerosis	9.48e-06	0.000289	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.15e-06	0.000279	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.08e-06	0.000277	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.85e-06	0.00027	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.74e-06	0.000266	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.34e-06	0.000254	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.32e-06	0.000254	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.22e-06	0.00025	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.86e-06	0.00024	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	7.85e-06	0.000239	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.44e-06	0.000227	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.36e-06	0.000224	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.26e-06	0.000221	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.23e-06	0.00022	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	6.86e-06	0.000209	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.85e-06	0.000209	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.76e-06	0.000206	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.51e-06	0.000198	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.5e-06	0.000198	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.46e-06	0.000197	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.4e-06	0.000195	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	5.95e-06	0.000181	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.93e-06	0.000181	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.88e-06	0.000179	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.66e-06	0.000172	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.59e-06	0.00017	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	4.88e-06	0.000149	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	4.84e-06	0.000147	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.7e-06	0.000143	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.36e-06	0.000133	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.3e-06	0.000131	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.22e-06	0.000129	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.12e-06	0.000125	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.07e-06	0.000124	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.06e-06	0.000124	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.88e-06	0.000118	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.7e-06	0.000113	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.65e-06	0.000111	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.34e-06	0.000102	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.32e-06	0.000101	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	3.19e-06	9.72e-05	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.79e-06	8.51e-05	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.76e-06	8.4e-05	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.19e-06	6.66e-05	CbGpPWpGaD
